Content:
Overview
Content on this page:
Overview
Content on this page:
Overview
Overview
Overactive bladder is also known as bladder spasms, suggestive of underlying detrusor overactivity (phasic increases in detrusor pressure)
It is a syndrome characterized by urinary urgency with or without frequency, nocturia and urgency incontinence.
Urogenital Distress Inventory (UDI), UDI-6 Short Form, Incontinence Impact Questionnaire (IIQ) and Overactive Bladder Questionnaire (OAB-q) and Patient Global Improvement (PGI) scale can be used to quantitate symptoms, evaluate changes with OAB therapies and assess patient’s sense of improvement.
The goals of treatment are to reduce urinary urgency and frequency, to increase voided volume (bladder capacity), and to decrease urge incontinence (reduce leakage episodes.
For further information regarding the management of Overactive Bladder, please refer to Disease Algorithm for the Treatment Guideline.
It is a syndrome characterized by urinary urgency with or without frequency, nocturia and urgency incontinence.
Urogenital Distress Inventory (UDI), UDI-6 Short Form, Incontinence Impact Questionnaire (IIQ) and Overactive Bladder Questionnaire (OAB-q) and Patient Global Improvement (PGI) scale can be used to quantitate symptoms, evaluate changes with OAB therapies and assess patient’s sense of improvement.
The goals of treatment are to reduce urinary urgency and frequency, to increase voided volume (bladder capacity), and to decrease urge incontinence (reduce leakage episodes.
For further information regarding the management of Overactive Bladder, please refer to Disease Algorithm for the Treatment Guideline.
